Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission

Objectives:The rate of vertical HIV transmission for women at high risk of HIV transmission stands at approximately 7.6%. In the present study we describe infant infection rates in women who had received raltegravir (RAL) intensification during pregnancy to a standard three-drug antiretroviral (ART)...

Full description

Bibliographic Details
Main Authors: Thanyawee Puthanakit, Nattawan Thepnarong, Surasith Chaithongwongwatthana, Suvaporn Anugulruengkitt, Orawan Anunsittichai, Tuangtip Theerawit, Sasiwimol Ubolyam, Chitsanu Pancharoen, Praphan Phanuphak
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Journal of Virus Eradication
Subjects:
raltegravir, HIV vertical transmission, prevention of mother-to-child transmission (PMTCT), high-risk HIV-positive pregnant women, late-presenting HIV
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020302466

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020302466

Similar Items